Patient experiences after surgery for benign prostatic hyperplasia
Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia.
Sahlgrenska University Hospital · NCT06852859
This study is trying to understand how men over 50 recover after surgery for an enlarged prostate by tracking their pain, urinary symptoms, and medication use for three months.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 50 Years and up |
| Sex | Male |
| Sponsor | Sahlgrenska University Hospital (other) |
| Locations | 3 sites (Alingsås and 2 other locations) |
| Trial ID | NCT06852859 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather detailed information on patients' recovery following surgery for benign prostatic hyperplasia (BPH). It will track pain levels, urinary symptoms, and medication use over a three-month period after three different surgical methods: transurethral resection, transurethral vaporization, and laser transurethral enucleation of the prostate. Patients will complete daily self-assessment forms to report their experiences, which will help researchers understand recovery patterns and symptom relief. The study will include 500 men over 50 years old who have been diagnosed with BPH and have an indication for surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are men over 50 years old diagnosed with benign prostatic hyperplasia who require surgical intervention.
Not a fit: Patients who do not speak Swedish may not benefit from this study due to language barriers in understanding and completing assessments.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into patient recovery and symptom management after BPH surgery, leading to improved postoperative care.
How similar studies have performed: While similar observational studies have been conducted, this specific approach focusing on patient-reported outcomes after different surgical methods for BPH is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing transurethral surgery for benign prostatic hyperplasia * Singed informed consent to participate Exclusion Criteria: * Non-swedish speaking patients
Where this trial is running
Alingsås and 2 other locations
- Alingsås lasarett, department of general surgery, urology and orthopaedic surgery — Alingsås, Sweden (RECRUITING)
- Kungälvs sjukhus, department of urology — Kungälv, Sweden (NOT_YET_RECRUITING)
- NU sjukvården, Uddevalla sjukhus, department of urology — Uddevalla, Sweden (NOT_YET_RECRUITING)
Study contacts
- Principal investigator: Joakim BE Strömberg, MD, PhD — Sahlgrenska University Hospital
- Study coordinator: Joakim BE Strömberg, MD, PhD
- Email: joakim.stromberg@vgregion.se
- Phone: 46-768-341-327
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Benign Prostatic Hyperplasia